• Discounts and special offers
  • Subscriber-only articles and interviews
  • Breaking news and trending topics

Already a subscriber?

By signing up, you accept Moneywise's Terms of Use, Subscription Agreement, and Privacy Policy.

Not interested ?

Seeking damages

The lawsuit claims that the 30-day notice period would have given Cole time to visit his doctor and request an exception to the price increase. It also alleges that he was not offered a free or discounted inhaler while he sought assistance from his provider and that Walgreens informed him that there were no lower-cost alternatives or generic options available.

Cole's parents say he had to choose between paying his rent and covering his medication. Five days later, he suffered a severe asthma attack and died due to cardiac arrest.

WSAZ News contacted Optum Rx for a response to the situation. A spokesperson wrote, “Mr. Schmidtknecht’s death was tragic, and our thoughts are with his family. The claims made are factually inaccurate.”

Walgreens declined to offer a comment.

Cole's death is not an isolated incident. The American Hospital Association reported that nearly 30% of Americans say they haven't taken their medication as prescribed due to the high cost. It also estimates more than a million Medicare patients could die in the next decade because they cannot afford their medications.

Invest in real estate without the headache of being a landlord

Imagine owning a portfolio of thousands of well-managed single family rentals or a collection of cutting-edge industrial warehouses. You can now gain access to a $1B portfolio of income-producing real estate assets designed to deliver long-term growth from the comforts of your couch.

The best part? You don’t have to be a millionaire and can start investing in minutes.

Learn More

How to deal with soaring prescription drug prices

As the cost of living increases, affording life-saving or even just life-improving medications has become a constant battle for many Americans. However, there are steps you can take to ensure you have the medication you need.

Look for discounts

Some pharmacies offer discounts or generic options for brand-name prescriptions. Always ask the pharmacy if there is a way to lower the price. Websites like GoodRX, SingleCare, or the manufacturer of the drug may also offer discounts if your insurance plan doesn't cover your medication.

Check for a patient assistance program

Many drug companies offer patient assistance programs (PAPs). These programs are designed to help those who can't afford their medications. Most have their own application process, and the requirements can vary. If you are low-income or your insurance does not cover the medication, you may qualify.

Consider other pharmacies

If your current pharmacy won't work with you, consider alternatives. Online pharmacies, like Cost Plus, have lower overhead costs, which allows them to offer prescription drugs at a reduced rate. Advair Diskus, the medication Cole required to treat his asthma, is available on the site for just under $100.

Talk to your doctor

If you're having trouble affording medications, your doctor may be your best resource. They may be able to switch your prescription to one your insurance covers or recommend a PAP to lower the cost. For some medications, the doctor may be able to offer samples or coupons.

Cole's death highlights a growing crisis in the U.S. If you are facing a similar struggle, there are options available.

The richest 1% use an advisor. Do you?

Wealthy people know that having money is not the same as being good with money. Advisor.com can help you shape your financial future and connect with expert guidance . A trusted advisor helps you make smart choices about investments, retirement savings, and tax planning.

Try it now
Danielle Antosz Freelance contributor

Danielle Antosz is a freelance contributor to Moneywise.

Disclaimer

The content provided on Moneywise is information to help users become financially literate. It is neither tax nor legal advice, is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional. We make no representation or warranty of any kind, either express or implied, with respect to the data provided, the timeliness thereof, the results to be obtained by the use thereof or any other matter. Advertisers are not responsible for the content of this site, including any editorials or reviews that may appear on this site. For complete and current information on any advertiser product, please visit their website.

†Terms and Conditions apply.